This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Celgene Corporation. Active years: 2019-2020.
Company Filing History:
Years Active: 2019-2020
Title: Innovations by Monica Leung in Psoriasis Treatment
Introduction
Monica Leung is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of immunology, particularly in the treatment of autoimmune diseases. With a total of 2 patents, her work focuses on innovative methods that utilize PD-1 binding antibodies.
Latest Patents
Monica's latest patents include groundbreaking methods for treating psoriasis using PD-1 binding antibodies. These methods provide new approaches for managing, treating, or preventing immune disorders, such as autoimmune diseases, by using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate its expression and activity. Additionally, she has developed compositions and methods involving antibodies that specifically bind to PD-1, further enhancing the understanding and treatment of immune-related conditions.
Career Highlights
Monica Leung is currently associated with Celgene Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential to transform treatment protocols for patients suffering from autoimmune diseases.
Collaborations
Monica collaborates with notable colleagues, including Henry Chan and Roli Khattri, who contribute to her research endeavors and help drive her innovative projects forward.
Conclusion
Monica Leung's contributions to the field of immunology, particularly through her patents related to PD-1 binding antibodies, highlight her role as a leading inventor in the treatment of autoimmune diseases. Her work promises to pave the way for new therapeutic strategies that can significantly improve patient outcomes.